Review questions clinical benefit of PCI in stable CAD

A meta-analysis of eight trials published in The Archives of Internal Medicine found that percutaneous coronary intervention had no clinical benefit over standard medical therapy in cases of stable coronary artery disease. However, physicians said there is still a place for stenting in treatment of the disease. "Cardiac disease is complicated, and there are lot of factors that go into assessing who should and shouldn’t be treated with stenting," said Dr. Allan Schwartz, who was not involved with the study.

View Full Article in: (Montreal) (free registration) · New York Times (tiered subscription model), The · HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA